Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc. is a publicly traded development stage company that is focused on expanding immune system stimulation to revolutionize vaccines. That is the company's quest. Stimulating the body's immune system remains one of the most promising approaches to addressing the unmet needs of cancer, HIV, hepatitis C virus, and other chronic infectious diseases. Inovio’s synthetic vaccine technology platform is progressively showing its potential to establish a new paradigm to prevent and treat these life altering diseases. The company has a growing pipeline of vaccine candidates based on this technology and has now advanced to Phase II clinical studies. These vaccines could potentially protect millions of people from sickness or death due to disease.

Search Projects

  • Vice President Research and Development
  • Vice President Quality Assurance